What does CUSIP 91307C102 represent in this 13F holders report?

CUSIP 91307C102 is the security identifier for UTHR - UNITED THERAPEUTICS Corp - Common Stock used to aggregate holder disclosures.

How many institutions held UTHR - UNITED THERAPEUTICS Corp - Common Stock in Q2 2014?

302 institutional investors reported UTHR - UNITED THERAPEUTICS Corp - Common Stock for Q2 2014. Use the holders table for investor-level position and value details.

UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / Common Stock
Shares outstanding: 42,833,193
Total 13F shares: 52,197,884
Share change: -1,544,594
Total reported value: $4,620,244,446
Put/Call ratio: 89%
Price per share: $88.49
Number of holders: 302
Value change: -$147,923,232
Number of buys: 144
Number of sells: 157

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 91307C102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BNP PARIBAS FINANCIAL MARKETS	13F	Company	29%	12,576,652	$2,654,535,970	—	31 Mar 2014	13F
FMR LLC	13F	Company	13%	5,781,388	$543,624,000	—	31 Mar 2014	13F
VANGUARD GROUP INC	13F	Company	7%	2,983,410	$280,530,000	—	31 Mar 2014	13F
AJO, LP	13F	Company	5%	2,158,250	$202,940,000	—	31 Mar 2014	13F
BlackRock Fund Advisors	13F	Company	4.6%	1,983,523	$186,511,000	—	31 Mar 2014	13F
DEUTSCHE BANK AG\	13F	Company	4.4%	1,900,151	$178,670,000	—	31 Mar 2014	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	4.4%	1,871,920	$176,019,000	—	31 Mar 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	4.2%	1,801,295	$169,376,000	—	31 Mar 2014	13F
LSV ASSET MANAGEMENT	13F	Company	4.1%	1,744,650	$164,049,000	—	31 Mar 2014	13F
BLACKROCK ADVISORS LLC	13F	Company	3.8%	1,644,365	$154,620,000	—	31 Mar 2014	13F
STATE STREET CORP	13F	Company	3.3%	1,429,609	$134,428,000	—	31 Mar 2014	13F
BANK OF MONTREAL /CAN/	13F	Company	3.2%	1,354,205	$127,336,000	—	31 Mar 2014	13F
BlackRock Investment Management, LLC	13F	Company	2.7%	1,171,724	$110,177,000	—	31 Mar 2014	13F
Invesco Ltd.	13F	Company	2.7%	1,161,821	$109,246,000	—	31 Mar 2014	13F
Palo Alto Investors LP	13F	Company	2.6%	1,101,028	$103,530,000	—	31 Mar 2014	13F
FIRST TRUST ADVISORS LP	13F	Company	2.2%	936,884	$88,095,000	—	31 Mar 2014	13F
Bank of New York Mellon Corp	13F	Company	2.1%	917,467	$86,269,000	—	31 Mar 2014	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.9%	805,557	$75,747,000	—	31 Mar 2014	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	1.7%	729,001	$68,547,964	—	31 Mar 2014	13F
TimesSquare Capital Management, LLC	13F	Company	1.6%	671,400	$63,132,000	—	31 Mar 2014	13F
Consonance Capital Management LP	13F	Company	1.6%	669,690	$62,971,000	—	31 Mar 2014	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	1.5%	645,763	$60,721,000	—	31 Mar 2014	13F
Winton Capital Management Ltd	13F	Company	1.3%	552,024	$51,907,000	—	31 Mar 2014	13F
RUSSELL FRANK CO/	13F	Company	1.2%	525,716	$49,438,000	—	31 Mar 2014	13F
JPMORGAN CHASE & CO	13F	Company	1.2%	514,469	$48,376,000	—	31 Mar 2014	13F
NORTHERN TRUST CORP	13F	Company	1.2%	505,122	$47,497,000	—	31 Mar 2014	13F
HERNDON CAPITAL MANAGEMENT LLC	13F	Company	1.1%	484,224	$45,531,582	—	31 Mar 2014	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.1%	468,617	$44,064,000	—	31 Mar 2014	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	1%	431,034	$40,530,000	—	31 Mar 2014	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.96%	410,844	$38,632,000	—	31 Mar 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.9%	386,158	$36,310,000	—	31 Mar 2014	13F
Numeric Investors LLC	13F	Company	0.88%	377,504	$35,497,000	—	31 Mar 2014	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.87%	374,051	$35,172,000	—	31 Mar 2014	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.8%	342,702	$32,224,000	—	31 Mar 2014	13F
Amici Capital, LLC	13F	Company	0.8%	342,399	$32,196,000	—	31 Mar 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.76%	326,364	$30,689,000	—	31 Mar 2014	13F
Allianz Asset Management GmbH	13F	Company	0.75%	319,234	$30,017,000	—	31 Mar 2014	13F
Gotham Asset Management, LLC	13F	Company	0.74%	316,489	$29,759,000	—	31 Mar 2014	13F
NEW AMSTERDAM PARTNERS LLC/NY	13F	Company	0.72%	308,956	$29,051,000	—	31 Mar 2014	13F
MORGAN STANLEY	13F	Company	0.71%	302,424	$28,438,000	—	31 Mar 2014	13F
NORGES BANK	13F	Company	0.7%	299,603	$28,172,000	—	31 Mar 2014	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.67%	287,940	$27,075,000	—	31 Mar 2014	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.67%	287,124	$26,998,000	—	31 Mar 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.65%	280,431	$26,368,000	—	31 Mar 2014	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	0.64%	272,100	$25,586,000	—	31 Mar 2014	13F
SMITH ASSET MANAGEMENT GROUP LP	13F	Company	0.61%	259,506	$24,401,000	—	31 Mar 2014	13F
FIRST QUADRANT LLC/CA	13F	Company	0.59%	250,800	$23,583,000	—	31 Mar 2014	13F
FRANKLIN RESOURCES INC	13F	Company	0.58%	247,600	$23,282,000	—	31 Mar 2014	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.57%	243,622	$23,000,000	—	31 Mar 2014	13F
BlackRock Finance, Inc.	13F	Company	0.56%	241,564	$22,714,000	—	31 Mar 2014	13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2014

As of 30 Jun 2014, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 302 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,197,884 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, DEUTSCHE BANK AG\, AJO, LP, BlackRock Fund Advisors, LSV ASSET MANAGEMENT, ACADIAN ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., State Street Corp, and TimesSquare Capital Management, LLC. This page lists 302 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

305

Q2 2014 holders

302

Holder diff

-3

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.